Occupational brucellosis in a veterinary assistant following exposure during management of bovine dystocia: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20254001Keywords:
Brucellosis, Occupational exposure, Veterinary assistant, Bovine dystocia, Sacroiliitis, Brucella abortusAbstract
Brucellosis remains a significant occupational zoonosis in India, particularly affecting workers in the veterinary and livestock sectors who frequently interact with infected animals and reproductive tissues. The disease is caused by gram-negative intracellular coccobacilli of the genus Brucella, with B. abortus being the predominant species associated with bovine brucellosis. Veterinary personnel performing high-exposure procedures such as dystocia management, placentectomy and handling of aborted materials face the greatest risk due to the heavy bacterial load present in reproductive tissues. We describe a case of acute brucellosis in a 34-year-old veterinary assistant who developed undulant fever, arthralgia, generalized myalgia, malaise and sacroiliac pain after unprotected exposure to reproductive secretions during manual management of bovine dystocia in a herd experiencing multiple late-term abortions. Herd screening revealed widespread Brucella abortus positivity. Initial evaluation showed leukopenia and a false-positive Widal test, leading to misdiagnosis as enteric fever. Persistent fever and musculoskeletal symptoms led to further investigation, and Brucella IgM ELISA returned strongly positive, confirming acute infection. The patient received WHO-recommended therapy with doxycycline and rifampicin for six weeks, resulting in full recovery without relapse over three months of follow-up. This case highlights the occupational risks faced by veterinary personnel, diagnostic challenges caused by nonspecific symptoms and serological cross-reactivity, and the critical need for strengthened biosafety practices and One-Health–oriented surveillance systems to reduce the burden of brucellosis in endemic regions.
Metrics
References
WHO. Brucellosis in Humans and Animals, 2006. Available at: https://apps.who.int/iris/handle/10665/43597. Accessed on 1 October 2025.
Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91-9. DOI: https://doi.org/10.1016/S1473-3099(06)70382-6
Mantur BG, Amarnath SK. Brucellosis in India-a review. J Biosci. 2008;33(4):539-47. DOI: https://doi.org/10.1007/s12038-008-0072-1
Renukaradhya GJ, Isloor S, Rajasekhar M. Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India. Vet Microbiol. 2002;90(1-4):183-95. DOI: https://doi.org/10.1016/S0378-1135(02)00253-5
Godfroid J, Scholz HC, Barbier T, Nicolas C, Wattiau P, Fretin D, et al. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Prev Vet Med. 2011;102(2):118-31. DOI: https://doi.org/10.1016/j.prevetmed.2011.04.007
Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007;7(12):775-86. DOI: https://doi.org/10.1016/S1473-3099(07)70286-4
Young EJ. Brucella species. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Elsevier. 2020.
Al Dahouk S, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti-Infect Ther. 2011;9(7):833-45. DOI: https://doi.org/10.1586/eri.11.55
Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36(1):S12-7. DOI: https://doi.org/10.1016/j.ijantimicag.2010.06.014
Mantur BG, Biradar MS, Bidri RC, Mallanna SM, Veerappa K, Piaraylal K, et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years’ experience. J Med Microbiol. 2006;55(7):897-903. DOI: https://doi.org/10.1099/jmm.0.46097-0
Tiwari AK, Shome R. Serological evidence of human brucellosis among high-risk individuals in India. Indian J Med Res. 2018;147(1):87-93.
WHO. Guidelines for the Treatment of Human Brucellosis, 2018. Available at: https://apps.who.int/iris/handle/10665/275854. Accessed on 1 October 2025.
Ariza J, Bosilkovski M, Cascio A, Juan DC, Michael JC, Matthew EF, et al. Perspectives for the treatment of human brucellosis in the 21st century. PLoS Med. 2007;4(12):e317. DOI: https://doi.org/10.1371/journal.pmed.0040317
Rahman MS. One Health approach for control of brucellosis in endemic countries. Infect Ecol Epidemiol. 2020;10(1):1792677.
CDC. Brucellosis Reference Guide: Exposures, Testing and Prevention. Centers for Disease Control and Prevention. 2022.